Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Sage Therapeutics (SAGE) has a market cap of $0.43 billion USD. According to our data, Sage Therapeutics is ranked No.6310 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $0.43 B |
28.27%
|
| Dec 31, 2024 | $0.33 B |
-74.94%
|
| Dec 29, 2023 | $1.33 B |
-43.18%
|
| Dec 30, 2022 | $2.33 B |
-10.34%
|
| Dec 31, 2021 | $2.60 B |
-50.83%
|
| Dec 31, 2020 | $5.29 B |
19.84%
|
| Dec 31, 2019 | $4.42 B |
-24.64%
|
| Dec 31, 2018 | $5.86 B |
-41.84%
|
| Dec 29, 2017 | $10.08 B |
222.58%
|
| Dec 30, 2016 | $3.12 B |
-12.42%
|
| Dec 31, 2015 | $3.57 B |
59.29%
|
| Dec 31, 2014 | $2.24 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
 Eli Lilly
LLY
|
$677.80 B |
-0.006 M
|
USA
|
 Johnson & Johnson
JNJ
|
$349.71 B |
-0.006 M
|
USA
|
 Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
 AbbVie
ABBV
|
$298.91 B |
0.013 M
|
USA
|
 Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
 Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
 Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
 Novartis
NVS
|
$196.25 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
 GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
| Market Cap | = | SAGE Stock Price | * | SAGE Shares Outstanding |
| = | $6.97 | * | 61.17 M | |
| = | $0.43 B |